Cited by 138Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome

Open access
Gerbaud, Edouard, Darier, Romain, Montaudon, Michel, Beauvieux, Marie-Christine, Coffin-Boutreux, Christine, Coste, Pierre, Douard, Hervé, Ouattara, Alexandre +1 more·2019·Diabetes Care

Abstract

OBJECTIVE: Acute glucose fluctuations are associated with hypoglycemia and are emerging risk factors for cardiovascular outcomes. However, the relationship between glycemic variability (GV) and the occurrence of midterm major cardiovascular events (MACE) in patients with diabetes remains unclear. This study investigated the prognostic value of GV in patients with diabetes and acute coronary syndrome (ACS). RESEARCH DESIGN AND METHODS: This study included consecutive patients with diabetes and ACS between January 2015 and November 2016. GV was assessed using SD during initial hospitalization. MACE, including new-onset myocardial infarction, acute heart failure, and cardiac death, were recorded. The predictive effects of GV on patient outcomes were analyzed with respect to baseline characteristics and cardiac status. RESULTS: A total of 327 patients with diabetes and ACS were enrolled. MACE occurred in 89 patients (27.2%) during a mean follow-up of 16.9 months. During follow-up, 24 patients (7.3%) died of cardiac causes, 35 (10.7%) had new-onset myocardial infarction, and 30 (9.2%) were hospitalized for acute heart failure. Multivariable logistic regression analysis showed that GV >2.70 mmol/L, a Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) score >34, and reduced left ventricular ejection fraction of <40% were independent predictors of MACE, with odds ratios (ORs) of 2.21 (95% CI 1.64–2.98; P < 0.001), 1.88 (1.26–2.82; P = 0.002), and 1.71 (1.14–2.54; P = 0.009), respectively, whereas a Global Registry of Acute Coronary Events (GRACE) risk score >140 was not (OR 1.07 [0.77–1.49]; P = 0.69). CONCLUSIONS: A GV cutoff value of >2.70 mmol/L was the strongest independent predictive factor for midterm MACE in patients with diabetes and ACS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc18-2047

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In Gerbaud et al, a glycemic variability cut-off of >2.70 mmol/L was the strongest independent predictive factor of MACE (OR 2.21, 1.64-0.98, p<0.001).

    “GV cut-off of >2.70 mmol/L was the strongest independent predictive factor of MACE: OR 2.21 (1.64–0.98), p<0.001.”
  • In patients with diabetes and acute coronary syndrome, a glycemic variability cut-off value of >2.70 mmol/L (49 mg/dL) was the strongest independent predictive factor of MACE, including new onset of myocardial infarction, acute heart failure and cardiac death.

    “Gerbaud et al42 reported that in patients with diabetes and acute coronary syndrome, a GV cut-off value of >2.70 mmol/L (49 mg/dL) was the strongest independent predictive factor of MACE, including new onset of myocardial infarction, acute heart failure and cardiac death.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for di- abetic complications. JAMA 2006;295:1707-1708
  2. Lachin JM, Genuth S, Nathan DM, Zinman B, Rutledge BN; DCCT/EDIC Research Group. Ef- fect of glycemic exposure on the risk of micro- vascular complications in the Diabetes Control and Complications Trialdrevisited. Diabetes 2008;57:995-1001

Cited by

Sorted by citations

Authors
Gerbaud, E., Darier, R., Montaudon, M., Beauvieux, M.-C., Coffin-Boutreux, C., Coste, P., Douard, H., Ouattara, A., & Catargi, B.
Affiliations
  • Cardiology Intensive Care Unit and Interventional Cardiology, Hôpital Cardiologique du Haut Lévêque, Pessac, France
  • Hôpital Cardiologique du Haut-Lévêque (FR)
  • Université de Bordeaux (FR)
  • Endocrinology-Nutrition Department, Centre Hospitalier de Périgueux, Périgueux, France
Corresponding author
Catargi, Bogdan
Venue
Diabetes Care
Published
2019-02-06
Volume
42
Issue
4
Pages
674-681
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2914109162
Cited by
138
References
40
Citations by year
2026: 7 · 2025: 20 · 2024: 17 · 2023: 15 · 2022: 23 · 2021: 29 · 2020: 18 · 2019: 9
FWCI
16.04
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
  • Oskar-Bordeaux (Universite de Bordeaux) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
glycemic variability, acute coronary syndrome, diabetes mellitus, major adverse cardiac events, prognostic factors, SYNTAX score, left ventricular ejection fraction, GRACE risk score, myocardial infarction, acute heart failure, cardiovascular mortality
MeSH terms
Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Hospitalization, Humans, Prognosis, Registries, Risk Factors, Diabetes Complications, Acute Coronary Syndrome, Percutaneous Coronary Intervention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review